{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:54:17Z","timestamp":1790963657465,"version":"4.1.0"},"reference-count":220,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Melanoma is one of the most lethal neoplasms of the skin. Despite the revolutionary introduction of immune checkpoint inhibitors, metastatic spread, and recurrence remain critical problems in resistant cases. Melanoma employs a multitude of mechanisms to subvert the immune system and successfully metastasize to distant organs. Concerningly, recent research also shows that tumor cells can disseminate early during melanoma progression and enter dormant states, eventually leading to metastases at a future time. Immune escape and metastasis have previously been viewed as separate phenomena; however, accumulating evidence is breaking down this dichotomy. Recent research into the progressive mechanisms of melanoma provides evidence that dedifferentiation similar to classical epithelial to mesenchymal transition (EMT), genes involved in neural crest stem cell maintenance, and hypoxia\/acidosis, are important factors simultaneously involved in immune escape and metastasis. The likeness between EMT and early dissemination, and differences, also become apparent in these contexts. Detailed knowledge of the mechanisms behind \u201cdual drivers\u201d simultaneously promoting metastatically inclined and immunosuppressive environments can yield novel strategies effective in disabling multiple facets of melanoma progression. Furthermore, understanding progression through these drivers may provide insight towards novel treatments capable of preventing recurrence arising from dormant dissemination or improving immunotherapy outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1336023","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:35:26Z","timestamp":1707885326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy"],"prefix":"10.3389","volume":"15","author":[{"given":"Carl A.","family":"Shirley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeba","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/OP.21.00686","article-title":"Managing metastatic melanoma in 2022: A clinical review","volume":"18","author":"Switzer","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4092","article-title":"The state of melanoma: emergent challenges and opportunities","volume":"27","author":"Atkins","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-020-01599-7","article-title":"Long non-coding rna linc00520 promotes the proliferation and metastasis of Malignant melanoma by inducing the Mir-125b-5p\/Eif5a2 axis","volume":"39","author":"Luan","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.575223","article-title":"Subversion of ras small gtpases in cutaneous melanoma aggressiveness","volume":"8","author":"Brito","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41419-021-03398-0","article-title":"Csn6 promotes melanoma proliferation and metastasis by controlling the Ubr5-mediated ubiquitination and degradation of Cdk9","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000576","article-title":"Decreased expression of nemo-like kinase in melanoma is correlated with increased vascularity and metastasis","volume":"29","author":"Yang","year":"2019","journal-title":"Melanoma Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108962","article-title":"Stress induced phosphoprotein 1 promotes tumor growth and metastasis of melanoma via modulating Jak2\/Stat3 pathway","volume":"116","author":"Sun","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in Keynote-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5524685","article-title":"Real-world survival in patients with metastatic melanoma after discontinuation of anti-Pd-1 immunotherapy for objective response or adverse effects: A retrospective study","volume":"2021","author":"Valentin","year":"2021","journal-title":"J Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41467-019-14218-7","article-title":"Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1","volume":"11","author":"Imbert","year":"2020","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: asco guideline update","volume":"41","author":"Seth","year":"2023","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1038\/s41467-020-17739-8","article-title":"Reversal of pre-existing ngfr-driven tumor and immune therapy resistance","volume":"11","author":"Boshuizen","year":"2020","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/critrevoncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S205160","article-title":"Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating Vegf-a\/Vegfr-2 and Vegf-C\/Vegfr-3 expression","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3390\/ijms22042219","article-title":"Runx3 induces a cell shape change and suppresses migration and metastasis of melanoma cells by altering a transcriptional profile","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01477-8","article-title":"The transcription factor Nrf2 enhances melanoma Malignancy by blocking differentiation and inducing cox2 expression","volume":"39","author":"Jessen","year":"2020","journal-title":"Oncogene"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.3390\/cancers12113366","article-title":"Shcd binds dock4, promotes ameboid motility and metastasis dissemination, predicting poor prognosis in melanoma","volume":"12","author":"Aladowicz","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1038\/s41467-020-18951-2","article-title":"Wnt11-fzd7-daam1 signalling supports tumour initiating abilities and melanoma amoeboid invasion","volume":"11","author":"Rodriguez-Hernandez","year":"2020","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274942","article-title":"Patterns of metastases progression- the linear parallel ratio","volume":"17","author":"Gofrit","year":"2022","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42002","article-title":"Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma","volume":"120","author":"Eyles","year":"2010","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43424","article-title":"Early Tumor Dissemination, but Late Metastasis: Insights into Tumor Dormancy","volume":"120","author":"Rocken","year":"2010","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41467-017-02674-y","article-title":"Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma","volume":"9","author":"Werner-Klein","year":"2018","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/cancers12082154","article-title":"Emt-inducing transcription factors, drivers of melanoma phenotype switching, and resistance to treatment","volume":"12","author":"Tang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41698-021-00200-4","article-title":"The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response","volume":"5","author":"Wang","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12093","article-title":"New insights into the role of emt in tumor immune escape","volume":"11","author":"Terry","year":"2017","journal-title":"Mol Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0336","article-title":"Epithelial-mesenchymal transition and immune evasion during lung cancer progression: the chicken or the egg","volume":"22","author":"Datar","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.41","article-title":"Decoding cancer\u2019s camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade","volume":"3","author":"Lotsberg","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor immune microenvironment during epithelial-mesenchymal transition","volume":"27","author":"Taki","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22190","article-title":"Immune system and melanoma biology: A balance between immunosurveillance and immune escape","volume":"8","author":"Passarelli","year":"2017","journal-title":"Oncotarget"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118958","article-title":"Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein tap-1 and loss of expression of the immunodominant Mart-1\/Melan-a antigen","volume":"98","author":"Maeurer","year":"1996","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.05.013","article-title":"Numerical defect of circulating dendritic cell subsets and defective dendritic cell generation from monocytes of patients with advanced melanoma","volume":"337","author":"Failli","year":"2013","journal-title":"Cancer Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1475-x","article-title":"Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients","volume":"62","author":"Jordan","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36022","article-title":"Ncrs and dnam-1 mediate nk cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo","volume":"119","author":"Lakshmikanth","year":"2009","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1230","article-title":"Nkg2d and mica\/B shedding: A \u2018Tag game\u2019 between Nk cells and Malignant cells","volume":"9","author":"Xing","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8359","DOI":"10.3390\/ijms21218359","article-title":"The influence of tumor microenvironment on immune escape of melanoma","volume":"21","author":"Simiczyjew","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/cells10040862","article-title":"Hypoxia and extracellular acidification as drivers of melanoma progression and drug resistance","volume":"10","author":"Dratkiewicz","year":"2021","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20057","article-title":"Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: A method for identifying cancers sensitive to arginine deprivation","volume":"100","author":"Dillon","year":"2004","journal-title":"Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00067","article-title":"Impact of L-arginine metabolism on immune response and anticancer immunotherapy","volume":"8","author":"Kim","year":"2018","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737461","article-title":"Pd-L2 expression extends beyond dendritic cells\/macrophages to B1 cells enriched for V(H)11\/V(H)12 and phosphatidylcholine binding","volume":"37","author":"Zhong","year":"2007","journal-title":"Eur J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"Pd-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in Pd-L1\/Pd-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.30","article-title":"Progressive upregulation of pd-1 in primary and metastatic melanomas associated with blunted tcr signaling in infiltrating T lymphocytes","volume":"131","author":"Chapon","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the pd-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci Adv"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90071-x","article-title":"Ctla-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1620","article-title":"Immune inhibitory molecules Lag-3 and Pd-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"Woo","year":"2012","journal-title":"Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0072","article-title":"Vista is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy","volume":"2","author":"Lines","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.08.002","article-title":"Targeting the Pd1\/Pd-L1 axis in melanoma: biological rationale, clinical challenges and opportunities","volume":"89","author":"Merelli","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"Vista is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724200","article-title":"Snail1: linking tumor metastasis to immune evasion","volume":"12","author":"Tang","year":"2021","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00031","article-title":"Phenotype switching in melanoma: implications for progression and therapy","volume":"5","author":"Li","year":"2015","journal-title":"Front Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3851576","article-title":"Epithelial-mesenchymal transition in skin cancers: A review","volume":"2019","author":"Hodorogea","year":"2019","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7443","article-title":"Axl is a marker for epithelial-mesenchymal transition in esophageal squamous cell carcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2373","article-title":"The emt transcription factor zeb2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype","volume":"80","author":"Vandamme","year":"2020","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16021","article-title":"Epithelial-to-mesenchymal-like transition events in melanoma","volume":"289","author":"Pedri","year":"2022","journal-title":"FEBS J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2016.01.025","article-title":"Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling","volume":"1863","author":"Paluncic","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049419","article-title":"Epithelial-mesenchymal-transition-like and tgfbeta pathways associated with autochthonous inflammatory melanoma development in mice","volume":"7","author":"Wehbe","year":"2012","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11706","article-title":"Mechanisms of jak-stat signaling pathway mediated by cxcl8 gene silencing on epithelial-mesenchymal transition of human cutaneous melanoma cells","volume":"20","author":"Hu","year":"2020","journal-title":"Oncol Lett"},{"key":"B65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13045-019-0711-z","article-title":"Downregulation of rnf128 activates wnt\/beta-catenin signaling to induce cellular emt and stemness via Cd44 and Cttn ubiquitination in melanoma","volume":"12","author":"Wei","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0204-6","article-title":"Cell-state dynamics and therapeutic resistance in melanoma from the perspective of mitf and ifngamma pathways","volume":"16","author":"Bai","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0664-4","article-title":"Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of tgf-beta1","volume":"37","author":"Yang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01649","article-title":"Notch signaling as a regulator of the tumor immune response: to target or not to target","volume":"9","author":"Janghorban","year":"2018","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00578","article-title":"Mtor at the transmitting and receiving ends in tumor immunity","volume":"9","author":"Guri","year":"2018","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.3390\/cancers13164040","article-title":"Pi3k\/akt pathway: the indestructible role of a vintage target as a support to the most recent immunotherapeutic approaches","volume":"13","author":"Caforio","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1101\/gad.284851.116","article-title":"A senescence secretory switch mediated by pi3k\/akt\/mtor activation controls chemoprotective endothelial secretory responses","volume":"30","author":"Bent","year":"2016","journal-title":"Genes Dev"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01148","article-title":"Immune system evasion as hallmark of melanoma progression: the role of dendritic cells","volume":"9","author":"Tucci","year":"2019","journal-title":"Front Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2797","article-title":"Effects of mapk and pi3k pathways on pd-L1 expression in melanoma","volume":"20","author":"Atefi","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051848","article-title":"The braf-mapk signaling pathway is essential for cancer-immune evasion in human melanoma cells","volume":"203","author":"Sumimoto","year":"2006","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00346","article-title":"Impact of mapk pathway activation in braf(V600) melanoma on T cell and dendritic cell function","volume":"4","author":"Ott","year":"2013","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.132","article-title":"Immunomodulating property of mapk inhibitors: from translational knowledge to clinical implementation","volume":"97","author":"Mandala","year":"2017","journal-title":"Lab Invest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1038\/s41467-021-26352-2","article-title":"Regulatory T cells promote cancer immune-escape through integrin alphavbeta8-mediated Tgf-beta activation","volume":"12","author":"Laine","year":"2021","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2698","article-title":"Induction of monocyte chemoattractant protein-1 and interleukin-10 by tgfbeta1 in melanoma enhances tumor infiltration and immunosuppression","volume":"71","author":"Diaz-Valdes","year":"2011","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2013.25.2.135","article-title":"Insights into the transforming growth factor-beta signaling pathway in cutaneous melanoma","volume":"25","author":"Perrot","year":"2013","journal-title":"Ann Dermatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2174\/138920111798808437","article-title":"Role of tgf-beta in melanoma","volume":"12","author":"Busse","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"B81","article-title":"Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis","volume":"86","author":"Ma","year":"1995","journal-title":"Immunology"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101010","article-title":"Hierarchy of tgfbeta\/smad, hippo\/yap\/taz, and wnt\/beta-catenin signaling in melanoma phenotype switching","volume":"5","author":"Luond","year":"2022","journal-title":"Life Sci Alliance"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02293","article-title":"Wnt\/beta-catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1238","article-title":"Myeloid-derived suppressor cells are a major source of Wnt5a in the melanoma microenvironment and depend on Wnt5a for full suppressive activity","volume":"81","author":"Douglass","year":"2021","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-88","article-title":"Wnt5a induces release of exosomes containing pro-angiogenic and immunosuppressive factors from Malignant melanoma cells","volume":"13","author":"Ekstrom","year":"2014","journal-title":"Mol Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/cells8091060","article-title":"An autocrine wnt5a loop promotes nf-kappab pathway activation and cytokine\/chemokine secretion in melanoma","volume":"8","author":"Barbero","year":"2019","journal-title":"Cells"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0302-0","article-title":"Sting signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001037","article-title":"Sox2 promotes resistance of melanoma with Pd-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by Saha","volume":"8","author":"Wu","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/ph14111081","article-title":"Egcg inhibits tumor growth in melanoma by targeting jak-stat signaling and its downstream Pd-L1\/Pd-L2-Pd1 axis in tumors and enhancing cytotoxic T-cell responses","volume":"14","author":"Ravindran Menon","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564450","article-title":"Loss of stat3 in murine Nk cells enhances nk cell-dependent tumor surveillance","volume":"124","author":"Gotthardt","year":"2014","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00779-1","article-title":"Multimodal pooled perturb-cite-seq screens in patient models define mechanisms of cancer immune evasion","volume":"53","author":"Frangieh","year":"2021","journal-title":"Nat Genet"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2005.08.036","article-title":"Stat5 contributes to interferon resistance of melanoma cells","volume":"15","author":"Wellbrock","year":"2005","journal-title":"Curr Biol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-005-1580-1","article-title":"Targeting stat3 affects melanoma on multiple fronts","volume":"24","author":"Kortylewski","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.247","article-title":"Macrophage-derived il-1beta stimulates wnt signaling and growth of colon cancer cells: A crosstalk interrupted by vitamin D3","volume":"28","author":"Kaler","year":"2009","journal-title":"Oncogene"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2014.05.003","article-title":"Ceacam1 promotes melanoma cell growth through Sox-2","volume":"16","author":"Ortenberg","year":"2014","journal-title":"Neoplasia"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110085","article-title":"Sox10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects","volume":"37","author":"Rosenbaum","year":"2021","journal-title":"Cell Rep"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1665976","article-title":"Hvem has a broader expression than pd-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma","volume":"8","author":"Malissen","year":"2019","journal-title":"Oncoimmunology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2078","article-title":"Sox10 regulates melanoma immunogenicity through an irf4-irf1 axis","volume":"81","author":"Yokoyama","year":"2021","journal-title":"Cancer Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10585-012-9545-6","article-title":"Ccl2 is critical for immunosuppression to promote cancer metastasis","volume":"30","author":"Kudo-Saito","year":"2013","journal-title":"Clin Exp Metastasis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ccr.2009.01.023","article-title":"Cancer metastasis is accelerated through immunosuppression during snail-induced emt of cancer cells","volume":"15","author":"Kudo-Saito","year":"2009","journal-title":"Cancer Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2147","article-title":"Milk fat globule egf-8 promotes melanoma progression through coordinated akt and twist signaling in the tumor microenvironment","volume":"68","author":"Jinushi","year":"2008","journal-title":"Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.3390\/ijms21207567","article-title":"Hypoxic melanoma cells deliver micrornas to dendritic cells and cytotoxic T lymphocytes through connexin-43 channels","volume":"21","author":"Tittarelli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd7455","article-title":"Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells","volume":"7","author":"Guo","year":"2021","journal-title":"Sci Adv"},{"key":"B104","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/ncomms6241","article-title":"Metastasis is regulated via microrna-200\/zeb1 axis control of tumour cell pd-L1 expression and intratumoral immunosuppression","volume":"5","author":"Chen","year":"2014","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13046-021-01916-8","article-title":"Mitf induces escape from innate immunity in melanoma","volume":"40","author":"Sanchez-Del-Campo","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2017.1323596","article-title":"Immune surveillance in melanoma: from immune attack to melanoma escape and even counterattack","volume":"18","author":"Mahmoud","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.10.014","article-title":"Microphthalmia-associated transcription factor (Mitf) regulates immune cell migration into melanoma","volume":"12","author":"Wiedemann","year":"2019","journal-title":"Transl Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.02.001","article-title":"Tumor plasticity and resistance to immunotherapy","volume":"6","author":"Horn","year":"2020","journal-title":"Trends Cancer"},{"key":"B109","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1038\/ncomms6712","article-title":"Low mitf\/axl ratio predicts early resistance to multiple targeted drugs in melanoma","volume":"5","author":"Muller","year":"2014","journal-title":"Nat Commun"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc8825","article-title":"Escape from nk cell tumor surveillance by ngfr-induced lipid remodeling in melanoma","volume":"9","author":"Lehmann","year":"2023","journal-title":"Sci Adv"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.873116","article-title":"Cancer cell phenotype plasticity as a driver of immune escape in melanoma","volume":"13","author":"Benboubker","year":"2022","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.756001","article-title":"Melanoma plasticity: promoter of metastasis and resistance to therapy","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0351","article-title":"Reemergence of neural crest stem cell-like states in melanoma during disease progression and treatment","volume":"10","author":"Diener","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000348418","article-title":"The neural crest and cancer: A developmental spin on melanoma","volume":"198","author":"Kulesa","year":"2013","journal-title":"Cells Tissues Organs"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12194","article-title":"Notch signaling in melanoma: interacting pathways and stromal influences that enhance notch targeting","volume":"27","author":"Bedogni","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2017.01.029","article-title":"Potential therapeutic targets of epithelial-mesenchymal transition in melanoma","volume":"391","author":"Pearlman","year":"2017","journal-title":"Cancer Lett"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.60655","article-title":"Sox10-mitf pathway activity in melanoma cells","volume":"13","author":"Tudrej","year":"2017","journal-title":"Arch Med Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.038","article-title":"Msx1-induced neural crest-like reprogramming promotes melanoma progression","volume":"138","author":"Heppt","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00111","article-title":"Stem cell-derived models of neural crest are essential to understand melanoma progression and therapy resistance","volume":"12","author":"Larribere","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.3390\/ijms22115761","article-title":"How neural crest transcription factors contribute to melanoma heterogeneity, cellular plasticity, and treatment resistance","volume":"22","author":"Wessely","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1217","article-title":"Cellular heterogeneity during embryonic stem cell differentiation to epiblast stem cells is revealed by the shcd\/ralp adaptor protein","volume":"30","author":"Turco","year":"2012","journal-title":"Stem Cells"},{"key":"B122","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/ijms23020849","article-title":"Hdac2 is involved in the regulation of brn3a in melanocytes and melanoma","volume":"23","author":"Heppt","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201862","article-title":"The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival","volume":"5","author":"Hohenauer","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41419-021-03890-7","article-title":"Comprehensive understanding of anchorage-independent survival and its implication in cancer metastasis","volume":"12","author":"Deng","year":"2021","journal-title":"Cell Death Dis"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64370","article-title":"Satb2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance","volume":"10","author":"Fazio","year":"2021","journal-title":"Elife"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s41467-020-15726-7","article-title":"Transcriptional downregulation of mhc class I and melanoma de- differentiation in resistance to pd-1 inhibition","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1496","article-title":"Neural crest-like stem cell transcriptome analysis identifies lpar1 in melanoma progression and therapy resistance","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02069-w","article-title":"The emerging roles of galpha12\/13 proteins on the hallmarks of cancer in solid tumors","volume":"41","author":"Rasheed","year":"2022","journal-title":"Oncogene"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0320","article-title":"Yap-induced pd-L1 expression drives immune evasion in Brafi-resistant melanoma","volume":"6","author":"Kim","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29353","article-title":"Ncam regulates the proliferation, apoptosis, autophagy, emt, and migration of human melanoma cells via the Src\/Akt\/Mtor\/Cofilin signaling pathway","volume":"121","author":"Li","year":"2020","journal-title":"J Cell Biochem"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.21037\/atm-21-4544","article-title":"Narrative review of emerging roles for Akt-Mtor signaling in cancer radioimmunotherapy","volume":"9","author":"Shen","year":"2021","journal-title":"Ann Transl Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1242\/dev.135426","article-title":"Ror2 signaling is required for local upregulation of Gdf6 and activation of bmp signaling at the neural plate border","volume":"143","author":"Schille","year":"2016","journal-title":"Development"},{"key":"B133","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1172\/JCI92513","article-title":"Ligand-activated bmp signaling inhibits cell differentiation and death to promote melanoma","volume":"128","author":"Venkatesan","year":"2018","journal-title":"J Clin Invest"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.jid.2021.01.021","article-title":"Bmp signaling promotes neural crest identity and accelerates melanoma onset","volume":"141","author":"Gramann","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward minimal residual disease-directed therapy in melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101971","article-title":"Antiangiogenic tumor therapy by DNA vaccine inducing aquaporin-1-specific ctl based on ubiquitin-proteasome system in mice","volume":"189","author":"Chou","year":"2012","journal-title":"J Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.490","article-title":"Cd271 on melanoma cell is an ifn-gamma-inducible immunosuppressive factor that mediates downregulation of melanoma antigens","volume":"134","author":"Furuta","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-5930fje","article-title":"Increased migration and metastatic potential of tumor cells expressing aquaporin water channels","volume":"20","author":"Hu","year":"2006","journal-title":"FASEB J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-01959-y","article-title":"The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells","volume":"98","author":"Andreucci","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"B140","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase ix in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8340926","article-title":"Anoikis resistance as a further trait of acidic-adapted melanoma cells","volume":"2019","author":"Peppicelli","year":"2019","journal-title":"J Oncol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13046-018-0915-z","article-title":"Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules","volume":"37","author":"Boussadia","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","article-title":"Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation","volume":"43","author":"Huber","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.celrep.2020.01.103","article-title":"Tumor-derived lactic acid contributes to the paucity of intratumoral ilc2s","volume":"30","author":"Wagner","year":"2020","journal-title":"Cell Rep"},{"key":"B146","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","article-title":"Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence","volume":"179","author":"Harel","year":"2019","journal-title":"Cell"},{"key":"B147","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/cells8020172","article-title":"Chronic hypoxia enhances beta-oxidation-dependent electron transport via electron transferring flavoproteins","volume":"8","author":"Fuhrmann","year":"2019","journal-title":"Cells"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0451-4","article-title":"Lipid metabolism in cancer cells under metabolic stress","volume":"120","author":"Munir","year":"2019","journal-title":"Br J Cancer"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2012.00989.x","article-title":"Reverse tca cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells","volume":"25","author":"Filipp","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B150","doi-asserted-by":"publisher","first-page":"e2302878120","DOI":"10.1073\/pnas.2302878120","article-title":"Cpt1a-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing","volume":"120","author":"Liu","year":"2023","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M604338200","article-title":"The ephb4 receptor-tyrosine kinase promotes the migration of melanoma cells through rho-mediated actin cytoskeleton reorganization","volume":"281","author":"Yang","year":"2006","journal-title":"J Biol Chem"},{"key":"B152","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.3390\/molecules25215115","article-title":"The pyrazolo[3,4-D]Pyrimidine-based kinase inhibitor nvp-bhg712: effects of regioisomers on tumor growth, perfusion, and hypoxia in ephb4-positive A375 melanoma xenografts","volume":"25","author":"Neuber","year":"2020","journal-title":"Molecules"},{"key":"B153","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/cells11010120","article-title":"Interleukin-8 in melanoma pathogenesis, prognosis and therapy-an integrated view into other neoplasms and chemokine networks","volume":"11","author":"Filimon","year":"2021","journal-title":"Cells"},{"key":"B154","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"Tgfbeta2-induced formation of lipid droplets supports acidosis-driven emt and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat Commun"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3257","article-title":"Inhibition of ephb4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers","volume":"79","author":"Bhatia","year":"2019","journal-title":"Cancer Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S245531","article-title":"Silencing tcf4 sensitizes melanoma cells to vemurafenib through inhibiting glut3-mediated glycolysis","volume":"13","author":"Liu","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.11.037","article-title":"A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma","volume":"187","author":"Pozniak","year":"2024","journal-title":"Cell."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2016.1175258","article-title":"The metabolic microenvironment of melanomas: prognostic value of mct1 and mct4","volume":"15","author":"Pinheiro","year":"2016","journal-title":"Cell Cycle"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111873","article-title":"The role of hypoxia-inducible factor-1alpha and its signaling in melanoma","volume":"141","author":"Malekan","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1968611","article-title":"\u201cSuffocating\u201d Tumors by blocking adaptation to hypoxia: A new headway in melanoma immunotherapy","volume":"10","author":"Janji","year":"2021","journal-title":"Oncoimmunology"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/med.21771","article-title":"The role of hypoxia-inducible factor 1 in tumor immune evasion","volume":"41","author":"You","year":"2021","journal-title":"Med Res Rev"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14002","article-title":"On the relationship between vdr, roralpha and rorgamma receptors expression and hif1-alpha levels in human melanomas","volume":"28","author":"Brozyna","year":"2019","journal-title":"Exp Dermatol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00187","article-title":"Th17 cells paradoxical roles in melanoma and potential application in immunotherapy","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208719","article-title":"Targeting stat3 blocks both hif-1 and vegf expression induced by multiple oncogenic growth signaling pathways","volume":"24","author":"Xu","year":"2005","journal-title":"Oncogene"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402552","article-title":"Cutting edge: hypoxia-inducible factor 1 negatively regulates th1 function","volume":"195","author":"Shehade","year":"2015","journal-title":"J Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250182","article-title":"Combination therapy of hif1alpha inhibitors and treg depletion strengthen the anti-tumor immunity in mice","volume":"53","author":"Wei","year":"2023","journal-title":"Eur J Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01846-x","article-title":"Targeting hif-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy","volume":"40","author":"Lequeux","year":"2021","journal-title":"Oncogene"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2022.061","article-title":"Anti-tumor effect of idf-11774, an inhibitor of hypoxia-inducible factor-1, on melanoma","volume":"30","author":"Kim","year":"2022","journal-title":"Biomol Ther (Seoul)"},{"key":"B170","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/ptr.6273","article-title":"Hif-1alpha\/vegf signaling-mediated epithelial-mesenchymal transition and angiogenesis is critically involved in anti-metastasis effect of luteolin in melanoma cells","volume":"33","author":"Li","year":"2019","journal-title":"Phytother Res"},{"key":"B171","doi-asserted-by":"publisher","first-page":"44","DOI":"10.14715\/cmb\/2023.69.5.8","article-title":"Functional involvement of adra1d in cutaneous melanoma progression and angiogenesis","volume":"69","author":"Wang","year":"2023","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00761-z","article-title":"Knockdown of fbxo22 inhibits melanoma cell migration, invasion and angiogenesis via the hif-1alpha\/vegf pathway","volume":"38","author":"Zheng","year":"2020","journal-title":"Invest New Drugs"},{"key":"B173","first-page":"2362","article-title":"Hif-inhibitor 64b induces necrosis and suppresses proliferation, metastasis and yap1 expression in mouse model of uveal melanoma","volume":"63","author":"Yang","year":"2022","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1038\/s41467-021-23042-x","article-title":"Egfr-hif1alpha signaling positively regulates the differentiation of il-9 producing T helper cells","volume":"12","author":"Roy","year":"2021","journal-title":"Nat Commun"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0360","article-title":"Anti-vegf treatment enhances cd8(+) T-cell antitumor activity by amplifying hypoxia","volume":"8","author":"de Almeida","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/cancers13081904","article-title":"Hypoxia-driven hif-1alpha activation reprograms pre-activated nk cells towards highly potent effector phenotypes via erk\/stat3 pathways","volume":"13","author":"Lim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B177","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/pcmr.12802","article-title":"Mitf controls the tca cycle to modulate the melanoma hypoxia response","volume":"32","author":"Louphrasitthiphol","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"B178","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/pcmr.12811","article-title":"Extracellular acidosis triggers a senescence-like phenotype in human melanoma cells","volume":"33","author":"Bohme","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00354-0","article-title":"Inhibition of host ogr1 enhances effector cd8(+) T-cell function by modulating acidic microenvironment","volume":"28","author":"Cao","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00370","article-title":"Ph sensing and regulation in cancer","volume":"4","author":"Damaghi","year":"2013","journal-title":"Front Physiol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33786","article-title":"Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors","volume":"149","author":"Mori","year":"2021","journal-title":"Int J Cancer"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2015.03.022","article-title":"Gpr4 decreases B16f10 melanoma cell spreading and regulates focal adhesion dynamics through the G13\/Rho signaling pathway","volume":"334","author":"Justus","year":"2015","journal-title":"Exp Cell Res"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12169","article-title":"Role of rho\/rock signaling in the interaction of melanoma cells with the blood-brain barrier","volume":"27","author":"Wilhelm","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B184","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/cancers11050631","article-title":"Emerging roles of the endoplasmic reticulum associated unfolded protein response in cancer cell migration and invasion","volume":"11","author":"Limia","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B185","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/cells9040989","article-title":"Extracellular acidosis promotes metastatic potency via decrease of the bmal1 circadian clock gene in breast cancer","volume":"9","author":"Kwon","year":"2020","journal-title":"Cells"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54090","article-title":"Bmal1 integrates mitochondrial metabolism and macrophage activation","volume":"9","author":"Alexander","year":"2020","journal-title":"Elife"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2017.12.013","article-title":"Circadian modification network of a core clock driver bmal1 to harmonize physiology from brain to peripheral tissues","volume":"119","author":"Tamaru","year":"2018","journal-title":"Neurochem Int"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181165","article-title":"Lrig1 acts as a critical regulator of melanoma cell invasion, migration, and vasculogenic mimicry upon hypoxia by regulating Egfr\/Erk-triggered epithelial-mesenchymal transition","volume":"39","author":"Li","year":"2019","journal-title":"Biosci Rep"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.341297","article-title":"Role of melanoma inhibitor of apoptosis (Ml-iap) protein, a member of the baculoviral iap repeat (Bir) domain family, in the regulation of C-raf kinase and cell migration","volume":"287","author":"Oberoi-Khanuja","year":"2012","journal-title":"J Biol Chem"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108073","article-title":"Birc2 expression impairs anti-cancer immunity and immunotherapy efficacy","volume":"32","author":"Samanta","year":"2020","journal-title":"Cell Rep"},{"key":"B191","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/cancers13040599","article-title":"Loss of ciap1 in endothelial cells limits metastatic extravasation through tumor-derived lymphotoxin alpha","volume":"13","author":"Vasilikos","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.10.030","article-title":"Iap antagonists induce autoubiquitination of C-iaps, Nf-Kappab activation, and Tnfalpha-dependent apoptosis","volume":"131","author":"Varfolomeev","year":"2007","journal-title":"Cell"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/srep30405","article-title":"Melanoma dormancy in a mouse model is linked to Gilz\/Foxo3a-dependent quiescence of disseminated stem-like cells","volume":"6","author":"Touil","year":"2016","journal-title":"Sci Rep"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2020.4964","article-title":"Foxo3asirt6 axis suppresses aerobic glycolysis in melanoma","volume":"56","author":"Dong","year":"2020","journal-title":"Int J Oncol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1111\/php.13305","article-title":"Crispr\/Cas9-mediated knockout of Sirt6 imparts remarkable antiproliferative response in human melanoma cells in vitro and in vivo","volume":"96","author":"Garcia-Peterson","year":"2020","journal-title":"Photochem Photobiol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2017.1384886","article-title":"Aberrant Sirt6 expression contributes to melanoma growth: role of the autophagy paradox and Igf-Akt signaling","volume":"14","author":"Wang","year":"2018","journal-title":"Autophagy"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.7150\/thno.29698","article-title":"Low levels of Sox2 are required for melanoma tumor-repopulating cell dormancy","volume":"9","author":"Jia","year":"2019","journal-title":"Theranostics"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.7150\/thno.63763","article-title":"Visualization of endogenous P27 and Ki67 reveals the importance of a C-myc-driven metabolic switch in promoting survival of quiescent cancer cells","volume":"11","author":"La","year":"2021","journal-title":"Theranostics"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1333","article-title":"The Pi3k\/Akt signaling pathway controls the quiescence of the low-rhodamine123-retention cell compartment enriched for melanoma stem cell activity","volume":"31","author":"Touil","year":"2013","journal-title":"Stem Cells"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201797673","article-title":"Ampk promotes survival of C-myc-positive melanoma cells by suppressing oxidative stress","volume":"37","author":"Kfoury","year":"2018","journal-title":"EMBO J"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000256090.42690.05","article-title":"Amp-activated protein kinase in metabolic control and insulin signaling","volume":"100","author":"Towler","year":"2007","journal-title":"Circ Res"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.95","article-title":"Ampk: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12964-018-0297-z","article-title":"Sox2 as a novel contributor of oxidative metabolism in melanoma cells","volume":"16","author":"Andreucci","year":"2018","journal-title":"Cell Commun Signal"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2011.188","article-title":"Sox2 contributes to melanoma cell invasion","volume":"92","author":"Girouard","year":"2012","journal-title":"Lab Invest"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00345","article-title":"Sox2 acts as a rheostat of epithelial to mesenchymal transition during neural crest development","volume":"5","author":"Mandalos","year":"2014","journal-title":"Front Physiol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-020-0264-5","article-title":"Tet2-mediated epigenetic drive for astrocyte differentiation from embryonic neural stem cells","volume":"6","author":"He","year":"2020","journal-title":"Cell Death Discovery"},{"key":"B207","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.immuni.2017.07.020","article-title":"The DNA methylcytosine dioxygenase tet2 sustains immunosuppressive function of tumor-infiltrating myeloid cells to promote melanoma progression","volume":"47","author":"Pan","year":"2017","journal-title":"Immunity"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1214","article-title":"Tet2-dependent hydroxymethylome plasticity reduces melanoma initiation and progression","volume":"79","author":"Bonvin","year":"2019","journal-title":"Cancer Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.28415","article-title":"Single-cell transcriptome analysis of avian neural crest migration reveals signatures of invasion and molecular transitions","volume":"6","author":"Morrison","year":"2017","journal-title":"Elife"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96329","article-title":"Stat3\/P53 pathway activation disrupts ifn-beta-induced dormancy in tumor-repopulating cells","volume":"128","author":"Liu","year":"2018","journal-title":"J Clin Invest"},{"key":"B211","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/emboj.2009.313","article-title":"Self-regulation of stat3 activity coordinates cell-cycle progression and neural crest specification","volume":"29","author":"Nichane","year":"2010","journal-title":"EMBO J"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00092","article-title":"Stem-mesenchymal signature cell genes detected in heterogeneous circulating melanoma cells correlate with disease stage in melanoma patients","volume":"7","author":"Rapanotti","year":"2020","journal-title":"Front Mol Biosci"},{"key":"B213","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.3390\/cancers14123030","article-title":"Heterogeneity in melanoma","volume":"14","author":"Ng","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B214","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1038\/s41467-022-34899-x","article-title":"Decoding molecular programs in melanoma brain metastases","volume":"13","author":"Radke","year":"2022","journal-title":"Nat Commun"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154804","article-title":"Mcp-1\/ccr2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression","volume":"7","author":"Pozzi","year":"2022","journal-title":"JCI Insight"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/cells12111513","article-title":"The vicious cycle of melanoma-microglia crosstalk: inter-melanoma variations in the brain-metastasis-promoting Il-6\/Jak\/Stat3 signaling pathway","volume":"12","author":"Izraely","year":"2023","journal-title":"Cells"},{"key":"B218","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.cell.2022.06.007","article-title":"Dissecting the treatment-naive ecosystem of human melanoma brain metastasis","volume":"185","author":"Biermann","year":"2022","journal-title":"Cell"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1489","article-title":"Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases","volume":"9","author":"Fischer","year":"2019","journal-title":"Cancer Discovery"},{"key":"B220","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41698-023-00471-z","article-title":"Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases","volume":"7","author":"In","year":"2023","journal-title":"NPJ Precis Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1336023\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:35:30Z","timestamp":1707885330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1336023\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":220,"alternative-id":["10.3389\/fimmu.2024.1336023"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1336023","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"article-number":"1336023"}}